Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Valeant Pharmaceuticals International, a multinational specialty pharmaceutical company, has appointed Steve Stefano to its board of directors. Mr Stefano's election brings the company's board to nine members.
Subscribe to our email newsletter
Mr Stefano is senior vice president of GlaxoSmithKline’s payor markets division and has spent 23 years leading GlaxoSmithKline’s managed markets division.
Mr Stefano has held numerous positions at the previous Glaxo Wellcome, inclusive of leading all of the company’s primary care sales force as well as heading up each of the oncology, HIV and neurohealth specialty divisions.
Michael Pearson, chairman and CEO of Valeant, said: “We are pleased to add someone of Steve’s caliber to our board. Given his experience in the managed care area, coupled with his leadership and experience at our partner GlaxoSmithKline, Steve will provide valuable insight and perspective to our already diverse board.”